首页> 外国专利> COMPOUNDS USEFUL FOR INHIBITING PARAMYXOVIRUS NEURAMINIDASE

COMPOUNDS USEFUL FOR INHIBITING PARAMYXOVIRUS NEURAMINIDASE

机译:抑制鼠伤寒病毒神经酰胺酶有用的化合物

摘要

Compounds represented by the formulae (A, B, C) wherein X is selected from the group consisting of: CHR, O, NR, N-OR, NR(O), S, S(O) and S(O)O X1 is selected from the group consisting of CR, N, and N(O); R is selected from the group consisting of: H, alkyl, alkene, alkyne, CN, NO2, N3, halo and NHR10; R1 is selected from the group consisting of: H, (CH2)nCO2R10, (CH2)n-tetrazol, (CH2)nSO3H, (CH2)nSO2H, (CH2)nPO3H2, (CH2)nCONR10, (CH2)nNO2, and (CH2)nCHO; R1a is selected from the group consisting of: H, (CH2)nOR10, (CH2)nCN, (CH2)nNR10R10a, (CH2)nNHC(O)R10, (CH2)nC(O)NR10R10a, and (CH2)nOC(O)R10; R1 and R1a both cannot be H each of R2 and R2a is independently selected from the group consisting of H, halo, CN, (CH2)nCO2R10, (CH2)nNR10R10a and (CH2)n-OR10; each of R3 and R3a is independently selected from the group consisting of: H, NHSO2R10, N(O)-SO2R10, NR10SO2R10a, (CH2)mYR10, and (CH2)mR6; at least one of R3 and R3a should be other than H Y is selected from the group consisting of: O, NH, NHC(O), C(O)NH, S, S(O), S(O)O, NHS(O)O, S(O)ONH, NHC(O)NH and heterocycle; R3 and R3a together may be =O, =CHR6, =CHR10, NR10 and =N-OR10 R4 and R4a is independently selected from the group consisting of: H, (CH2)mYR10 and (CH2)mYR10 and (CH2)mR6 R4 and R4a together may be: =O, =CHR6, =CHR10, =NR10 and =N-OR10 each of R5 and R5a is independently selected from the group consisting of C(R7)(R7a), C(R7)(R7a)C(R8)(R8a), C(R7)(R7a)C(R8)(R8a)C(R9)(R9a), OC(R7)(R7a), OC(R7)(R7a)C(R8)(R8a), C(R7)(R¿7a)OC(R8)(R8a), N(R10)C(R7)(R7a), N(R10)C(R7)(R7a)C(R8)(R8a), C(R7)(R7a)N(R10)C(R8a), and C(O)NR10R10a; R6 is selected from the group consisting of H, halo, CN, NO2, N3, CO2R¿10, R¿10? and NR10R10a; R7, R7a, R8, R8a, R9 and R9a is selected from the group from the group consisting of: H, (CH2)mYR10 and (CH2)mR6 each of the R10 and R10a is individually selected from the groups consisting of: H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heterocycle, substituted heterocycle, alkenyl, substituted alkenyl, alkynyl, and substituted alkynyl; each of m and n is individually O, 1, 2, 3, or 4; and pharmaceutically acceptable salt thereof; and prodrugs thereof, and uses thereof.
机译:由式(A,B,C)表示的化合物,其中X选自:CHR,O,NR,N-OR,NR(O),S,S(O)和S(O)O X1选自CR,N和N(O); R选自:H,烷基,烯烃,炔,CN,NO 2,N 3,卤素和NHR 10; R1选自:H,(CH2)nCO2R10,(CH2)n-四唑,(CH2)nSO3H,(CH2)nSO2H,(CH2)nPO3H2,(CH2)nCONR10,(CH2)nNO2和( CH2)nCHO; R1a选自:H,(CH2)nOR10,(CH2)nCN,(CH2)nNR10R10a,(CH2)nNHC(O)R10,(CH2)nC(O)NR10R10a和(CH2)nOC( O)R10; R1和R1a都不能为H R2和R2a各自独立地选自H,卤素,CN,(CH2)nCO2R10,(CH2)nNR10R10a和(CH2)n-OR10; R3和R3a各自独立地选自:H,NHSO2R10,N(O)-SO2R10,NR10SO2R10a,(CH2)mYR10和(CH2)mR6; R3和R3a中至少一个不是HY选自:O,NH,NHC(O),C(O)NH,S,S(O),S(O)O,NHS( O)O,S(O)ONH,NHC(O)NH和杂环; R3和R3a一起可以是= O,= CHR6,= CHR10,NR10和= N-OR10 R4和R4a独立地选自:H,(CH2)mYR10和(CH2)mYR10以及(CH2)mR6 R4 R5a和R4a一起可以是:= O,= CHR6,= CHR10,= NR10和= N-OR10 R5和R5a各自独立地选自C(R7)(R7a),C(R7)(R7a) C(R8)(R8a),C(R7)(R7a)C(R8)(R8a)C(R9)(R9a),OC(R7)(R7a),OC(R7)(R7a)C(R8)( R8a),C(R7)(R¿7a)OC(R8)(R8a),N(R10)C(R7)(R7a),N(R10)C(R7)(R7a)C(R8)(R8a) ,C(R7)(R7a)N(R10)C(R8a)和C(O)NR10R10a; R 6选自H,卤素,CN,NO 2,N 3,CO 2 R 10,R 10。和NR10R10a; R 7,R 7a,R 8,R 8a,R 9和R 9a选自:H,(CH 2)m YR 10和(CH 2)m R 6每个R 10和R 10a分别选自:H,烷基,取代的烷基,芳基,取代的芳基,芳基烷基,取代的芳基烷基,杂环,取代的杂环,烯基,取代的烯基,炔基和取代的炔基; m和n分别为O,1、2、3或4;及其药学上可接受的盐;及其前药及其用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号